Data Characteristics
Phase I clinical research documents include study protocols, investigator brochures, informed consent forms, case report forms (CRFs), and safety reports. These documents are typically in PDF format. Content covers subject recruitment criteria, dosing, pharmacokinetic (PK)/pharmacodynamic (PD) data, adverse event (AE) records, laboratory test results, and statistical analysis plans. Document structures are highly standardized, adhering to ICH GCP and regulatory requirements from various countries. Data update frequency is relatively low, primarily occurring during protocol amendments, safety data aggregation, or final report publication. Fields include dose units (e.g., mg/kg), time points (e.g., hours, days), subject IDs, and various biomarker indicators.
Constraints on Vector Models and Indexing
The highly standardized structure of Phase I clinical documents allows for fine-grained text chunking and metadata extraction using chapter headings, table structures, and key fields within the documents. This enhances retrieval accuracy. The low update frequency means index rebuilding costs are manageable, avoiding frequent full updates. However, documents contain extensive specialized terminology, numbers, and units. Vector models must accurately capture the semantics of this specialized information and differentiate subtle variations between different drugs, dosages, or time points. Detailed descriptions of adverse events in safety reports often require models to identify causal relationships and event sequences. Cross-references between documents, such as supporting literature cited in study protocols, necessitate an index capable of establishing inter-document relationships.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Length) | 500–800 characters | Balances contextual completeness with retrieval granularity, preventing information loss. |
Chunk Overlap Length (Overlap) | 50–100 characters | Ensures continuity of information across chunks, capturing context. |
embedding_model | Calibrate by testing | Prioritize models that perform well in the biomedical domain. |
Recall count (Recall Count) | 10–20 | Covers more potentially relevant results, improving recall rate. |
Similarity threshold (Similarity Threshold) | 0.7–0.8 | Filters out irrelevant results, ensuring retrieval quality. |
retrieval_strategy | hybrid | Combines keyword and vector retrieval to handle specialized terminology. |
Common Pitfalls
- Query results contain many irrelevant or duplicate passages. This is due to overly fine chunking granularity or excessive overlap, leading to insufficient generalization capability of vector representations.
- Specific drug names or dosage data are not accurately recalled. This typically happens when the chosen vector model lacks sufficient recognition capability for specific entities in the biomedical domain.
- New information is not reflected in retrieval after document updates. This indicates that the index update mechanism is not effectively synchronized with the document management system, or the update frequency is set incorrectly.
Validation Steps
- Perform multiple rounds of question-answering against test sets covering different study phases, drugs, and adverse events. Observe the accuracy and completeness of retrieval results.
- Check the recall of key fields (e.g., drug names, dosages, time points). Ensure specialized terminology and numerical information are correctly identified.
- Simulate document update operations. Verify that the index can quickly and accurately reflect the latest content after data changes by comparing retrieval results before and after the update.
Note: The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.